Wei Lin Chung-Hsing Chou Fu-Chi Yang Chia-Kuang Tsai Yu-Kai Lin Yueh-Feng Sung
10.3389/fimmu.2023.1115120
Front Immunol
2023 Apr 14;14:1115120.
aquaporin-4 antibody fingolimod rebound syndrome fingolimod withdrawal syndrome neuromyelitis optica spectrum disorder relapse-remitting multiple sclerosis
CC BY
https://pubmed.ncbi.nlm.nih.gov/37122715/
Multiple Sclerosis / drug therapy Multiple Sclerosis, Relapsing-Remitting / drug therapy Neuromyelitis Optica / diagnosis Neuromyelitis Optica / drug therapy Neuromyelitis Optica / pathology
Multiple Sclerosis / drug therapy Multiple Sclerosis, Relapsing-Remitting / drug therapy Neuromyelitis Optica / diagnosis Neuromyelitis Optica / drug therapy Neuromyelitis Optica / pathology Case Reports Female Fingolimod Hydrochloride / adverse effects Humans Immunologic Factors / therapeutic use Middle Aged Fingolimod Hydrochloride Immunologic Factors
PMC10140362
37122715
Case Report: Severe rebound after withdrawal of fingolimod in a patient with neuromyelitis optica spectrum disorder
2023